Literature DB >> 16535923

[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?].

Luca Miele1, Maria L Gabrieli, Alessandra Forgione, Vittoria Vero, Antonella Gallo, Esmeralda Capristo, Giovanni Gasbarrini, Antonio Grieco.   

Abstract

Metabolic syndrome (MS) is a worldwide medical problem characterized by a cluster of cardiovascular risk factors and metabolic modifications involving peripheral insulin resistance. Nonalcoholic steatohepatitis (NASH) represents the liver expression of this pathological condition. Both MS and NASH are characterized by proinflammatory status and increased oxidative stress. According this, we aimed to review the literature for considering a possible role for vitamins as therapeutical support in MS and NASH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16535923

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN: 0034-1193


  3 in total

1.  Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats.

Authors:  Koji Fujita; Masato Yoneda; Koichiro Wada; Hironori Mawatari; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Shiro Maeyama; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Atsushi Nakajima
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

2.  Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH).

Authors:  Jianfeng Cheng; Andrew Joyce; Katherine Yates; Bradley Aouizerat; Arun J Sanyal
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

3.  Kaempferol Attenuates ROS-Induced Hemolysis and the Molecular Mechanism of Its Induction of Apoptosis on Bladder Cancer.

Authors:  Ping Wu; Xiaofeng Meng; Huade Zheng; Qin Zeng; Tianfeng Chen; Wen Wang; Xia Zhang; Jianyu Su
Journal:  Molecules       Date:  2018-10-10       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.